Tissue factor pathway inhibitor in activated prothrombin complex concentrates (aPCC) moderates the effectiveness of therapy in some severe hemophilia A patients with inhibitor - Ogiwara, K; Nogami, K; Matsumoto, T; Shima, M (Int J Hematol, 2014)